Guillermina Maier

Starlight Ventures Management LLC (Starlight Ventures) is a venture capital firm founded in 2017 by Patricia Halfen Wexler and Matias Mosse. The firm is headquartered in Miami, Florida.

InterCement Brasil SA produces and sells cement, limestone, and mortar products. It also engages in services which includes conrcretes, aggregates, concessions, co-processing, and trading & shipping. The company was founded in 1968 and is headquartered in São Paulo, Brazil.

Part of Loma Negra Compañía Industrial Argentina SA, Ferrosur Roca SA provides rail freight forwarding and storage services.

Molino Cañuelas SACIFIA engages in the production of consumer products. It offers vegetable oil, flour, biscuits, cookies and crackers, ready-mixed and bread crumb products. It operates through the following segments: Retail Products; Branded Industrial Products; and Agro-Services and Sustainable Sourcing. The Retail Products segment markets its products under the Cañuelas, Pureza, and Florencia brands. The Branded Industrial Products segment offers its products under the Cañuelas, Florencia, Multi-Harina, Adelia María, Favorita, Leticia, Terminada, Rosafe, San Agustín, and Pigüé brands. The Agro-Services and Sustainable Sourcing segment provides seeds, fertilizers, farm machinery, and other goods, as well as insurance brokerage services. The company was founded in 1970 and is headquartered in Cañuelas, Argentina.

Greenstone Capital LLP (Greenstone Capital) is an Independent Private Equity firm founded in 2013 by Michael John Haworth and Mark Raymond Sawyer. The firm is headquartered in London.

AptaTargets SL is a biopharmaceutical company based in Madrid, Spain that focuses on developing therapeutic applications based on aptamer technology. The Spanish company is currently developing aptoll, an immune modulator that blocks the activation of tlr4 in a stroke, representing a novel approach to treat ischemic stroke in the acute phase. It could also be administered in patients up to 48 hours after the stroke. AptaTargets targets indications where inflammation causes significant damage through clinical studies and successful preclinical development. The company was founded in 2014 by David Segarra and María Eugenia Zarabozo, with David Segarra serving as the CEO since then.

GlyCardial Diagnostics SL has developed a biomarker called iSCOR that can detect cardiac ischemia through a blood test. The company is based in Barcelona, Spain. Early detection of ischemia can prevent myocardial damage. The Spanish company was founded in 2017 by Rafols Judit Cubedo, Lina Badimon Maestro, Capmany Teresa Padro, and Gemma Vilahur. Rafols Judit Cubedo has been the CEO since 2017.

Sanifit Therapeutics SA develops pharmaceuticals for calcification disorders. Its pipeline consists of treatments for calcification disorders, such as calciphylaxis and osteoporosis. The company was founded by Felix Grases in 2004 and is headquartered in Palma de Mallorca, Spain.

SpliceBio SL is a genetic medicines company based in Barcelona, Spain. The Spanish company harnesses its proprietary protein splicing platform to develop the next generation of gene therapies. SpliceBio's platform offers the potential to address diseases that currently cannot be treated with gene therapies because the necessary gene is too large to be delivered by -associated virus (AAV) vectors. The company's lead program targets Stargardt disease, a genetic eye disease that causes vision loss in children and adults. SpliceBio's platform is based on technology developed in the Muir lab at Princeton University after more than 20 years of pioneering intein and protein engineering research. The company was founded by Dominguez Silvia Frutos, Miquel Vila-Perelló, and Miquel Vila-Perelló has been the CEO since incorporation.

Iproteos SL engages in research and development for schizophrenia treatment. It specializes in the research and development of third-generation drugs for human diseases. The company was founded by Ernest Giralt and Teresa Tarragó and is headquartered in Barcelona, Spain.

Aelix Therapeutics SL researches and develops therapies for HIV. It develops therapeutic vaccines and immunotherapies to treat HIV infection. The firm is a spin-off of HIVACAT, the Catalan project for the development of effective vaccines against HIV. The company was founded by Christian Brander, Bonaventura Clotet, Josep Maria Gatell and Jordi Naval is headquartered in Barcelona, Spain.

Medlumics SL provides medical imaging diagnostics services. It specializes in optically guided medical devices. The firm’s proprietary integrated optics platform technology combines optical and electrical components in a miniature chip, enabling for the first time complex multi view optical probes of the size of a grain of rice and ultra-portable, hand-held OCT systems that produces real-time images. The company was founded by Eduardo Margallo Balbás and Jose Luis Rubio Guivernau on April 3, 2009 and is headquartered in Tres Cantos, Spain.

Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain.

Epiris Managers LLP (Epiris) is a private equity firm founded in 1976. The firm is headquartered in London.

Yguazú Cementos SA engages in the production and distribution of cement. It sells Cemento Portland Compuesto CPII and Cemento Portland Fillerizado CPII. The company was founded on June 10, 2000 and is headquartered in Barrio Jara, Paraguay.

Get Pegasus, Inc. provides information technology services. It specializes in performance management, productivity, team development and human resources. The company was founded by Parker Mitchell and is headquartered in FL.

The Portland Cement Association (California) is a professional organization.

Part of Recursion Pharmaceuticals, Inc., Valence Discovery, Inc. is a Canadian company committed to unlocking the true potential of deep learning in drug design. The company is based in Montréal, Canada, and is pioneering the application of few-shot learning in drug design. Valence's AI-enabled drug design platform has been extensively validated and is currently being used to identify and design drug candidates in collaboration with industry-leading partners. The company is developing and deploying novel machine learning methods for molecular property prediction, generative chemistry, and multiparameter optimization. The company was founded by Sebastian Giguere, Prudencio Tossou, Daniel Cohen, Therence Bois, Sebastien Giguere, and Daniel Cohen has been the CEO since incorporation. Valence Discovery was acquired by Recursion Pharmaceuticals, Inc. on May 16, 2023 for $35.35 million.

Syncari, Inc. engages in the provision of data automation platform solutions. It helps businesses regain control on data sources and integratons through data cleansing, merging, and augmentation. The company was founded by Nick Bonfiglio and Neelesh Shastry in 2019 and is headquartered in Newark, CA.

InterCement Participações SA operates as a holding company with interest in manufacturing and selling cement and cement products. The company is headquartered in São Paulo, Brazil.

Part of Loma Negra Compañía Industrial Argentina SA, Recycomb SA is an Argentinean company that provides industrial chemical recycling services. The company is based in Uribelarrea, Argentina.

Cristacol SA is a production company. It is engaged in the in the marketing of paints and varnishes for road marking. The company is headquartered in Buenos Aires, Argentina.

Administradora Nazca Ventures SA (Nazca) is a venture capital subsidiary of Mountain Partners AG founded in 2012. It is headquartered in Coral Gables, Florida, the United States with additional offices in Mexico and Santiago, Chile.

Caixa Capital Risc SGEIC SA (Caixa Capital Risc) is a venture capital armof Criteria Caixa SA founded in 2002. The firm is headquartered in Barcelona, Spain with additional offices in Madrid.

Rhombuz VC (Rhombuz) is a private equity firm founded in 2013. The firm is headquartered in Hong Kong.